- Trials with a EudraCT protocol (39,320)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39,320 result(s) found for: 1.
Displaying page 1,680 of 1,966.
| EudraCT Number: 2011-003087-70 | Sponsor Protocol Number: PM1125 | Start Date*: 2011-12-02 |
| Sponsor Name:Polichem SA | ||
| Full Title: Randomized, open-label, controlled study on the efficacy of Ciclopoli® (ciclopirox 8% nail lacquer) versus Loceryl® (amorolfine 5% nail lacquer) on the culture conversion to negative in patients w... | ||
| Medical condition: distal subungual onychomycosis without lunula involvement due to fungal nail pathogens (dermatophytes, white yeasts and/or Scopulariopsis spp. and/or Fusarium spp.) affecting at least one big toenail | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: LV (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000389-12 | Sponsor Protocol Number: 3.0 | Start Date*: 2013-09-11 |
| Sponsor Name:Cardiff University | ||
| Full Title: ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Randomised Double-blind Placebo Controlled Trial | ||
| Medical condition: Aggression and challenging behaviour in adults with learning disabilities | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-000364-16 | Sponsor Protocol Number: CELYVIR | Start Date*: 2011-02-07 |
| Sponsor Name:FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO NIÑO JESUS | ||
| Full Title: Ensayo clínico abierto de fase I para evaluar la eficacia y seguridad del tratamiento con células mesenquimales autólogas infectadas con un nuevo adenovirus oncolítico en el tratamiento de paciente... | ||
| Medical condition: Niños con tumor sólido refractario o recidivante a dos o más líneas de tratamiento estándar de los siguientes diagnósticos histológicos: neuroblastoma estadio IV, sarcoma de Ewing con metástasis ós... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-005208-14 | Sponsor Protocol Number: R17548 | Start Date*: 2012-06-18 | |||||||||||
| Sponsor Name:Norfolk and Norwich University Hospitals NHS Foundation Trust | |||||||||||||
| Full Title: Innovative Gel Aid for Administering Tablets to Stroke and Other Dysphagic Patients | |||||||||||||
| Medical condition: Healthy volunteers will be used in the study however the gel device being investigated has been developed with the aim of aiding swallowing in stroke and other dysphagic patients. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-015730-30 | Sponsor Protocol Number: 2009-23 | Start Date*: 2009-10-13 |
| Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
| Full Title: OPTIMISATION DE L’EVALUATION DE LA FONCTION SURRENALIENNE APRES ARRET D’UNE CORTICOTHERAPIE PROLONGEE | ||
| Medical condition: L’ insuffisance surrénale post-corticothérapie | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-004269-15 | Sponsor Protocol Number: D-13-01 | Start Date*: 2014-03-17 |
| Sponsor Name:Insituto Aragonés de Ciencias de la Salud | ||
| Full Title: Aspirin and colorectal cancer prevention. Exploring the platelet hypothesis of its mechanism of action | ||
| Medical condition: We will perform this clinical study to address the hypothesis that low-dose aspirin given once daily is acting primarily by selectively acetylating platelet COX-1 and suppressing its activity throu... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001834-16 | Sponsor Protocol Number: AD101_01 | Start Date*: 2014-01-10 | |||||||||||
| Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | |||||||||||||
| Full Title: EVALUATION OF SEIZURE CONTROL AND QUALITY OF LIFE IN PATIENTS WITH BRAIN TUMOR RELATED EPILEPSY TREATED WITH LACOSAMIDE AS ADD-ON THERAPY: A PROSPECTIVE EXPLORATIVE STUDY | |||||||||||||
| Medical condition: PATIENTS WITH BRAIN TUMOR RELATED EPILEPSY | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-003547-39 | Sponsor Protocol Number: 46077 | Start Date*: 2013-10-15 | |||||||||||||||||||||||||||||||
| Sponsor Name:Isala Klinieken | |||||||||||||||||||||||||||||||||
| Full Title: Dexmedetomidine vs. clonidine in delirious intensive care patients: a randomised open-label trial | |||||||||||||||||||||||||||||||||
| Medical condition: (ICU- associated) Delirium | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2013-001743-31 | Sponsor Protocol Number: NL43882.029.13 | Start Date*: 2013-08-06 | |||||||||||
| Sponsor Name:VU University Medical Center | |||||||||||||
| Full Title: The cardiovascular effects of hyperoxia during and shortly after CABG surgery | |||||||||||||
| Medical condition: During and after coronary artery bypass graft operation we will investigate the cardiovascular effects of hyperoxia on blood pressure, cardiac function, microcirculation and ischemia/reperfusion. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-005745-20 | Sponsor Protocol Number: IPR/26 | Start Date*: 2013-03-24 |
| Sponsor Name:MolMed S.p.A. | ||
| Full Title: NGR018: Randomized phase II study of NGR-hTNF plus an anthracycline versus an anthracycline alone in platinum-resistant ovarian cancer | ||
| Medical condition: Advanced or metastatic platinum-resistant ovarian cancer patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005700-28 | Sponsor Protocol Number: AIDA_104599 | Start Date*: 2016-04-20 | |||||||||||
| Sponsor Name:Erasmus MC | |||||||||||||
| Full Title: An evaluation of the effectivity of the current treatment of uncomplicated urinary tract infections with fosfomycin. | |||||||||||||
| Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-005536-17 | Sponsor Protocol Number: IIBSP-CIP-2013-166 | Start Date*: 2014-08-18 |
| Sponsor Name:Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau | ||
| Full Title: Multicenter, randomized and double-blinded clinical trial on the use of antibiotic prophylaxis for EUS guided FNA of pancreatic cystic lesions | ||
| Medical condition: Pancreatic cystic lesions | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001959-24 | Sponsor Protocol Number: BoTN-Study | Start Date*: 2014-08-26 |
| Sponsor Name:University Hospital Essen | ||
| Full Title: BoTN: Onabotulinumtoxin A for the treatment of trigeminal neuralgia: Efficacy, safety and neurophysiological alterations under therapy – a prospective, controlled trial | ||
| Medical condition: Trigeminal neuralgia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004797-33 | Sponsor Protocol Number: Obstetrics1.0 | Start Date*: 2018-06-13 |
| Sponsor Name:CHU Tivoli | ||
| Full Title: The efficacy of continuous ropivacaine wound infusion after cesarean delivery in pain management. | ||
| Medical condition: Poor postoperative pain control leads to decreased satisfaction with care, prolonged recovery time and increased use of health care resources. Despite their efficacy, opioids are associated with na... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005092-24 | Sponsor Protocol Number: FSJD-PIOSPIMET-2015 | Start Date*: 2016-01-22 |
| Sponsor Name:FUNDACIÓ SANT JOAN DE DÉU | ||
| Full Title: A prospective, open-label, randomized, two-armed clinical trial to evaluate the efficacy and safety of a combination of ethinyl-estradiol and levonorgestrel versus a low-dose combination of pioglit... | ||
| Medical condition: ovarian hyperandrogenism with hyperinsulinaemia | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003541-17 | Sponsor Protocol Number: FIMHCSBR-2017 | Start Date*: 2018-10-24 |
| Sponsor Name:FIMABIS Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud [...] | ||
| Full Title: Neuropsiquiatric Evolution After Introduction of Raltegravir QD in substitution of dolutegravir: NEAR QD Study | ||
| Medical condition: Human Inmunodeficiency Virus Infection (HIV) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004184-36 | Sponsor Protocol Number: UKER-AN-HS-01 | Start Date*: 2016-01-05 | |||||||||||
| Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
| Full Title: Prospective, randomised, double-blind, placebo-controlled, single centre phase IIa clinical trial to investigate the safety and tolerability as well as the impact of a substitution of sexual hormon... | |||||||||||||
| Medical condition: Substitution of sexual hormones in adult females with anorexia nervosa | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-003338-15 | Sponsor Protocol Number: RBHP2014ELJEZI | Start Date*: 2014-12-01 | |||||||||||
| Sponsor Name:CHU de Clermont-Ferrand | |||||||||||||
| Full Title: Role of Nitric Oxide (NO) in pre-oxygenation before anesthetic induction in patients with Pulmonary Hypertension (PH) in cardiac surgery. Feasibility study. | |||||||||||||
| Medical condition: - Cardiac surgery open heart - Pulmonary Hypertension with PAPs> 40 mmHg secondary to left heart disease or COPD (class 2 or 3), diagnosed by preoperative right heart catheterization or transthora... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-001474-41 | Sponsor Protocol Number: 17-014 | Start Date*: 2017-07-26 | |||||||||||
| Sponsor Name:CHU CAEN | |||||||||||||
| Full Title: Bénéfices de la perfusion continue de lidocaïne intraveineuse en chirurgie bariatrique : une étude randomisée prospective contre placebo | |||||||||||||
| Medical condition: Patients obèses éligibles et programmés pour une chirurgie bariatrique | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-003427-38 | Sponsor Protocol Number: HGT-GCB-068 | Start Date*: 2016-04-07 | |||||||||||
| Sponsor Name:Shire Human Genetic Therapies | |||||||||||||
| Full Title: A Multi-center, Open-label, Efficacy and Safety Study of Velaglucerase Alfa Enzyme Replacement Therapy in Children and Adolescents With Type 3 Gaucher Disease | |||||||||||||
| Medical condition: Type 3 Gaucher disease | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.